The Medicinal Cannabis market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Medicinal Cannabis market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Medicinal Cannabis market. The report focuses on well-known providers in the global Medicinal Cannabis industry, market segments, competition, and the macro environment.
Under COVID-19 Outbreak, how the Medicinal Cannabis Industry will develop is also analyzed in detail in Chapter 1.7 of the report.
In Chapter 2.4, we analyzed industry trends in the context of COVID-19.
In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.
In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.
In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.
A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.
Key players in the global Medicinal Cannabis market covered in Chapter 4:
Botanix Pharmaceuticals
MMJ Phytotech
Oxford Cannabinoid Technologies
MGC Pharmaceuticals
European Cannabis Holdings
Queensland Bauxite
AusCann Group
GW Pharmaceuticals
Medlab Clinical
Cann Group
In Chapter 11 and 13.3, on the basis of types, the Medicinal Cannabis market from 2015 to 2026 is primarily split into:
Tetrahydrocannabinol (THC)
Cannabidiol (CBD)
In Chapter 12 and 13.4, on the basis of applications, the Medicinal Cannabis market from 2015 to 2026 covers:
Cancer
Arthritis
Epilepsy
Neurological Disease
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:
North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 9 and 13)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2026
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global Medicinal Cannabis Market Share by Type (2020-2026)
1.5.2 Tetrahydrocannabinol (THC)
1.5.3 Cannabidiol (CBD)
1.6 Market by Application
1.6.1 Global Medicinal Cannabis Market Share by Application (2020-2026)
1.6.2 Cancer
1.6.3 Arthritis
1.6.4 Epilepsy
1.6.5 Neurological Disease
1.6.6 Others
1.7 Medicinal Cannabis Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on Medicinal Cannabis Industry Development
2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19
3 Value Chain of Medicinal Cannabis Market
3.1 Value Chain Status
3.2 Medicinal Cannabis Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of Medicinal Cannabis
3.2.3 Labor Cost of Medicinal Cannabis
3.2.3.1 Labor Cost of Medicinal Cannabis Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19
4 Players Profiles
4.1 Botanix Pharmaceuticals
4.1.1 Botanix Pharmaceuticals Basic Information
4.1.2 Medicinal Cannabis Product Profiles, Application and Specification
4.1.3 Botanix Pharmaceuticals Medicinal Cannabis Market Performance (2015-2020)
4.1.4 Botanix Pharmaceuticals Business Overview
4.2 MMJ Phytotech
4.2.1 MMJ Phytotech Basic Information
4.2.2 Medicinal Cannabis Product Profiles, Application and Specification
4.2.3 MMJ Phytotech Medicinal Cannabis Market Performance (2015-2020)
4.2.4 MMJ Phytotech Business Overview
4.3 Oxford Cannabinoid Technologies
4.3.1 Oxford Cannabinoid Technologies Basic Information
4.3.2 Medicinal Cannabis Product Profiles, Application and Specification
4.3.3 Oxford Cannabinoid Technologies Medicinal Cannabis Market Performance (2015-2020)
4.3.4 Oxford Cannabinoid Technologies Business Overview
4.4 MGC Pharmaceuticals
4.4.1 MGC Pharmaceuticals Basic Information
4.4.2 Medicinal Cannabis Product Profiles, Application and Specification
4.4.3 MGC Pharmaceuticals Medicinal Cannabis Market Performance (2015-2020)
4.4.4 MGC Pharmaceuticals Business Overview
4.5 European Cannabis Holdings
4.5.1 European Cannabis Holdings Basic Information
4.5.2 Medicinal Cannabis Product Profiles, Application and Specification
4.5.3 European Cannabis Holdings Medicinal Cannabis Market Performance (2015-2020)
4.5.4 European Cannabis Holdings Business Overview
4.6 Queensland Bauxite
4.6.1 Queensland Bauxite Basic Information
4.6.2 Medicinal Cannabis Product Profiles, Application and Specification
4.6.3 Queensland Bauxite Medicinal Cannabis Market Performance (2015-2020)
4.6.4 Queensland Bauxite Business Overview
4.7 AusCann Group
4.7.1 AusCann Group Basic Information
4.7.2 Medicinal Cannabis Product Profiles, Application and Specification
4.7.3 AusCann Group Medicinal Cannabis Market Performance (2015-2020)
4.7.4 AusCann Group Business Overview
4.8 GW Pharmaceuticals
4.8.1 GW Pharmaceuticals Basic Information
4.8.2 Medicinal Cannabis Product Profiles, Application and Specification
4.8.3 GW Pharmaceuticals Medicinal Cannabis Market Performance (2015-2020)
4.8.4 GW Pharmaceuticals Business Overview
4.9 Medlab Clinical
4.9.1 Medlab Clinical Basic Information
4.9.2 Medicinal Cannabis Product Profiles, Application and Specification
4.9.3 Medlab Clinical Medicinal Cannabis Market Performance (2015-2020)
4.9.4 Medlab Clinical Business Overview
4.10 Cann Group
4.10.1 Cann Group Basic Information
4.10.2 Medicinal Cannabis Product Profiles, Application and Specification
4.10.3 Cann Group Medicinal Cannabis Market Performance (2015-2020)
4.10.4 Cann Group Business Overview
5 Global Medicinal Cannabis Market Analysis by Regions
5.1 Global Medicinal Cannabis Sales, Revenue and Market Share by Regions
5.1.1 Global Medicinal Cannabis Sales by Regions (2015-2020)
5.1.2 Global Medicinal Cannabis Revenue by Regions (2015-2020)
5.2 North America Medicinal Cannabis Sales and Growth Rate (2015-2020)
5.3 Europe Medicinal Cannabis Sales and Growth Rate (2015-2020)
5.4 Asia-Pacific Medicinal Cannabis Sales and Growth Rate (2015-2020)
5.5 Middle East and Africa Medicinal Cannabis Sales and Growth Rate (2015-2020)
5.6 South America Medicinal Cannabis Sales and Growth Rate (2015-2020)
6 North America Medicinal Cannabis Market Analysis by Countries
6.1 North America Medicinal Cannabis Sales, Revenue and Market Share by Countries
6.1.1 North America Medicinal Cannabis Sales by Countries (2015-2020)
6.1.2 North America Medicinal Cannabis Revenue by Countries (2015-2020)
6.1.3 North America Medicinal Cannabis Market Under COVID-19
6.2 United States Medicinal Cannabis Sales and Growth Rate (2015-2020)
6.2.1 United States Medicinal Cannabis Market Under COVID-19
6.3 Canada Medicinal Cannabis Sales and Growth Rate (2015-2020)
6.4 Mexico Medicinal Cannabis Sales and Growth Rate (2015-2020)
7 Europe Medicinal Cannabis Market Analysis by Countries
7.1 Europe Medicinal Cannabis Sales, Revenue and Market Share by Countries
7.1.1 Europe Medicinal Cannabis Sales by Countries (2015-2020)
7.1.2 Europe Medicinal Cannabis Revenue by Countries (2015-2020)
7.1.3 Europe Medicinal Cannabis Market Under COVID-19
7.2 Germany Medicinal Cannabis Sales and Growth Rate (2015-2020)
7.2.1 Germany Medicinal Cannabis Market Under COVID-19
7.3 UK Medicinal Cannabis Sales and Growth Rate (2015-2020)
7.3.1 UK Medicinal Cannabis Market Under COVID-19
7.4 France Medicinal Cannabis Sales and Growth Rate (2015-2020)
7.4.1 France Medicinal Cannabis Market Under COVID-19
7.5 Italy Medicinal Cannabis Sales and Growth Rate (2015-2020)
7.5.1 Italy Medicinal Cannabis Market Under COVID-19
7.6 Spain Medicinal Cannabis Sales and Growth Rate (2015-2020)
7.6.1 Spain Medicinal Cannabis Market Under COVID-19
7.7 Russia Medicinal Cannabis Sales and Growth Rate (2015-2020)
7.7.1 Russia Medicinal Cannabis Market Under COVID-19
8 Asia-Pacific Medicinal Cannabis Market Analysis by Countries
8.1 Asia-Pacific Medicinal Cannabis Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Medicinal Cannabis Sales by Countries (2015-2020)
8.1.2 Asia-Pacific Medicinal Cannabis Revenue by Countries (2015-2020)
8.1.3 Asia-Pacific Medicinal Cannabis Market Under COVID-19
8.2 China Medicinal Cannabis Sales and Growth Rate (2015-2020)
8.2.1 China Medicinal Cannabis Market Under COVID-19
8.3 Japan Medicinal Cannabis Sales and Growth Rate (2015-2020)
8.3.1 Japan Medicinal Cannabis Market Under COVID-19
8.4 South Korea Medicinal Cannabis Sales and Growth Rate (2015-2020)
8.4.1 South Korea Medicinal Cannabis Market Under COVID-19
8.5 Australia Medicinal Cannabis Sales and Growth Rate (2015-2020)
8.6 India Medicinal Cannabis Sales and Growth Rate (2015-2020)
8.6.1 India Medicinal Cannabis Market Under COVID-19
8.7 Southeast Asia Medicinal Cannabis Sales and Growth Rate (2015-2020)
8.7.1 Southeast Asia Medicinal Cannabis Market Under COVID-19
9 Middle East and Africa Medicinal Cannabis Market Analysis by Countries
9.1 Middle East and Africa Medicinal Cannabis Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Medicinal Cannabis Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Medicinal Cannabis Revenue by Countries (2015-2020)
9.1.3 Middle East and Africa Medicinal Cannabis Market Under COVID-19
9.2 Saudi Arabia Medicinal Cannabis Sales and Growth Rate (2015-2020)
9.3 UAE Medicinal Cannabis Sales and Growth Rate (2015-2020)
9.4 Egypt Medicinal Cannabis Sales and Growth Rate (2015-2020)
9.5 Nigeria Medicinal Cannabis Sales and Growth Rate (2015-2020)
9.6 South Africa Medicinal Cannabis Sales and Growth Rate (2015-2020)
10 South America Medicinal Cannabis Market Analysis by Countries
10.1 South America Medicinal Cannabis Sales, Revenue and Market Share by Countries
10.1.1 South America Medicinal Cannabis Sales by Countries (2015-2020)
10.1.2 South America Medicinal Cannabis Revenue by Countries (2015-2020)
10.1.3 South America Medicinal Cannabis Market Under COVID-19
10.2 Brazil Medicinal Cannabis Sales and Growth Rate (2015-2020)
10.2.1 Brazil Medicinal Cannabis Market Under COVID-19
10.3 Argentina Medicinal Cannabis Sales and Growth Rate (2015-2020)
10.4 Columbia Medicinal Cannabis Sales and Growth Rate (2015-2020)
10.5 Chile Medicinal Cannabis Sales and Growth Rate (2015-2020)
11 Global Medicinal Cannabis Market Segment by Types
11.1 Global Medicinal Cannabis Sales, Revenue and Market Share by Types (2015-2020)
11.1.1 Global Medicinal Cannabis Sales and Market Share by Types (2015-2020)
11.1.2 Global Medicinal Cannabis Revenue and Market Share by Types (2015-2020)
11.2 Tetrahydrocannabinol (THC) Sales and Price (2015-2020)
11.3 Cannabidiol (CBD) Sales and Price (2015-2020)
12 Global Medicinal Cannabis Market Segment by Applications
12.1 Global Medicinal Cannabis Sales, Revenue and Market Share by Applications (2015-2020)
12.1.1 Global Medicinal Cannabis Sales and Market Share by Applications (2015-2020)
12.1.2 Global Medicinal Cannabis Revenue and Market Share by Applications (2015-2020)
12.2 Cancer Sales, Revenue and Growth Rate (2015-2020)
12.3 Arthritis Sales, Revenue and Growth Rate (2015-2020)
12.4 Epilepsy Sales, Revenue and Growth Rate (2015-2020)
12.5 Neurological Disease Sales, Revenue and Growth Rate (2015-2020)
12.6 Others Sales, Revenue and Growth Rate (2015-2020)
13 Medicinal Cannabis Market Forecast by Regions (2020-2026)
13.1 Global Medicinal Cannabis Sales, Revenue and Growth Rate (2020-2026)
13.2 Medicinal Cannabis Market Forecast by Regions (2020-2026)
13.2.1 North America Medicinal Cannabis Market Forecast (2020-2026)
13.2.2 Europe Medicinal Cannabis Market Forecast (2020-2026)
13.2.3 Asia-Pacific Medicinal Cannabis Market Forecast (2020-2026)
13.2.4 Middle East and Africa Medicinal Cannabis Market Forecast (2020-2026)
13.2.5 South America Medicinal Cannabis Market Forecast (2020-2026)
13.3 Medicinal Cannabis Market Forecast by Types (2020-2026)
13.4 Medicinal Cannabis Market Forecast by Applications (2020-2026)
13.5 Medicinal Cannabis Market Forecast Under COVID-19
14 Appendix
14.1 Methodology
14.2 Research Data Source
Research Methodology
It is a well-organized procedure to carry out research. We at Market Growth Insight follow global, all-inclusive & iterative research methodology to develop our research reports. We are using both the top down as well as bottom-up approaches for partitioning and evaluating the significant aspects of the market.
It is a systematic & strategic approach for conducting a market study. Our market research methodology is based on the concept that gives a detailed description of the factors behind an observation. Let us see the detailed market research methodology.
Primary Data Research
It is the very basic stage of research the raw data is obtained and collected on a boarded front.Data is constantly filtered to ensure that only validated and authenticated sources are considered. Moreover,information is also mined from a large group of reports in our vault, as well as various reputed paid databases. It is necessary to understand the entire value chain and in order to facilitate this; we gather information from raw material suppliers, distributors as well as buyers, for extensive knowledge of the market.
The technical issues and trends are acquired from reviews, technical discussion and trade journals. Moreover, the technical data is also accumulated from intellectual property prospective, focusing on a void area and freedom of movement. The industry elements regarding drivers, restraints, pricing trends are also collected. Subsequently, the material developed contains a wide range of original and unique information that is then further cross-validated and authenticated with published sources.
Statistical Model
Simulation models are responsible to estimate and forecast our market, and for each research, a unique model is created and customized. The data accumulated for market dynamics, innovation scene, application improvement, estimating trends is delivered into the model and analyzedsimultaneously. These components are examined on a comparative basis, and their impact on the figure of the frame is measured with the assistance of correlation, regression and time series investigation. Forecasting of the market is performed through the consolidation of economic tools, innovative examination, and industry experience along with domain expertise. Generally, economic models are utilized for short-termforecasting, technological market models are used for long-term forecasting of a market. These are based on an amalgamation of technology innovation, regulatory frameworks, economic outlook, and business principles. A bottom-up approach to the market estimation is preferred, with key regional markets analyzed as separate entities and integration of information to get a worldwide evaluation. This is very critical for a deep knowledge of the business as well as ensuring negligible mistakes. Below mentioned are some of the parameters are considered for forecasting
Market drivers and restraints, along with their current and expected impact
Raw material scenario and supply v/s price trends
Regulatory situation and expected developments
Current capacity and expected capacity additions up to 2025
Market driving organizations
The key targets of essential research are as per the following
To approve our information as far as exactness and adequacy
To pick up an understanding of the present market and future desires
We dole out weights to these parameters and evaluate their market effect utilizing weighted normal examination, to infer a normal market development rate.
This is the last advance in assessing and anticipating for our reports. Thorough essential meetings are led, on up close and personal and additionally via telephone to approve our discoveries and suppositions used to get them. Interviewees are drawn closer from driving organizations over the esteem chain including providers, innovation suppliers, area specialists,and purchasers in order to guarantee an all-encompassing and fair photo of the market. Essential meetings help in information approval, as well as give basic bits of knowledge into the market, current business situation and future desires and upgrade the nature of our reports. Every one of our assessments and figure is checked through comprehensive essential research with Key Industry Participants (KIPs) which ordinarily include:
Preliminary Investigation
This is the closing phase in estimating and forecasting for our reports. In this stage face to face and telephonic exhaustive interviews are conducted to validate our conclusion and assumptions used to obtain the final data. The leading companies across the value chain including suppliers, technology providers, domain experts,and purchasers are approaching the interviewees to ensure a holistic and unbiased view of the market. These interviews are led over the world, with language boundaries defeat with the guide of local staff and translators. Primary interviews in information validation as well as give critical insights into the market, current business outline and future expectations upgrade the quality of our reports. All our estimates and forecast are verified through exhaustive primary research with Key Industry Participants include
Leading market organizations
The key targets of primary research are as per the following:
To validate our data as far as exactness and adequacy
To pick up an understanding into the present market and future desires
Select License
Payment
Why Choose Us
